Abstract:Objective·To investigate the insulin resistance in liver cirrhosis patients.Methods·Patients with liver cirrhosis from Xinhua Hospital,Shanghai Jiao Tong University School of Medicine in 2013‒2017 were retrospectively assessed. Biochemical indexes, including fasting blood glucose (FBG), glycosylated hemoglobin A1c (HbA1c), fasting insulin and homeostatic model assessment-insulin resistance (HOMA-IR), were collected. The complications of liver cirrhosis were recorded, including esophagogastric varices bleeding (EVB), ascites and hepatic encephalopathy (HE). According to HOMA-IR value, the liver cirrhosis patients were divided into non-insulin resistance group (IR≤1.64) and insulin resistance group (IR>1.64). Various indicators were compared between the two groups.Results·A total of 376 patients with liver cirrhosis were included in this study. The proportions of Child-Pugh A, Child-Pugh B and Child-Pugh C were 162 (43.09%), 148 (39.36%), and 66 (17.55%), respectively. The main cause of liver cirrhosis was hepatitis B virus infection 163 (43.35%). Fasting insulin levels were measured in 208 of 376 liver cirrhosis patients. Among them, 117 patients (56.25%) had no insulin resistance and 91 patients (43.75%) had insulin resistance. The body mass index (BMI) of liver cirrhosis patients in the insulin resistance group was significantly higher than that in the non-insulin resistance group (P=0.000), and the prevalence of type 2 diabetes in the former was also higher (P=0.001). The scores of Child-Pugh in patients with liver cirrhosis in the insulin resistance group were lower than those in the non-insulin resistance group, and the difference in Child-Pugh score was statistically significant (6.93±1.99 vs 7.63±2.20, P=0.020). The proportion of Child-Pugh C grade in the insulin resistance group was significantly lower than that in the patients without insulin resistance (P=0.028). The prevalence of ascites in cirrhotic patients with insulin resistance was significantly lower than that in cirrhotic patients without insulin resistance (36.26% vs 66.67%, P=0.000). There was no significant difference in the prevalence of EVB and HE between the two groups (P>0.05).Conclusion·Nearly half of patients with liver cirrhosis are associated with insulin resistance. Compared with no-insulin resistance patients, cirrhotic patients with insulin resistance have a higher BMI, lower percentage of Child-Pugh C, and fewer ascites prevalence.

Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis

A cross-sectional study of the relationship between serum liver enzymes level and the incidence of impaired fasting glucose in males and females.

Dietary Inflammatory Potential is Associated with Higher Odds of Hepatic Steatosis in US Adults: a Cross-Sectional Study

Dietary Inflammatory and Insulinemic Potential, Risk of Hepatocellular Carcinoma, and Chronic Liver Disease Mortality.

Association of Inflammatory and Insulinemic Potential of Diet and Lifestyle with Risk of Hepatocellular Carcinoma.

Diets with higher insulinaemic potential are associated with increased risk of overall and cardiovascular disease-specific mortality

Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis

Association of Dietary Insulinemic and Inflammatory Potential with Risk of Liver Cancer and Chronic Liver Disease Mortality in Postmenopausal Women: a Prospective Cohort Study.

The association of dietary and lifestyle indices for hyperinsulinemia with odds of non-alcoholic fatty liver disease in Iranian adults: a case–control study

Associations Between Serum Glucose, Insulin, Insulin Resistance and the Risk of Incident Primary Liver Cancer or Chronic Liver Disease Mortality: a Nested Case–control Study

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease

Predictors Of Hepatic Steatosis In Hbeag-Negative Chronic Hepatitis B Patients And Their Diagnostic Values In Hepatic Fibrosis

Clinical analysis of insulin resistance in liver cirrhosis patients

Associations of total protein, albumin, and globulin with insulin resistance: an NHANES study

Dietary insulin index and dietary insulin load in relation to non-alcoholic fatty liver disease: a cross-sectional study

Study on the Relationship Between Insulin Growth Factor 1 and Liver Fibrosis in Patients with Chronic Hepatitis C with Type 2 Diabetes Mellitus.

Dietary Insulinemic Potential and Risk of Total and Cause-Specific Mortality in the Nurses' Health Study and the Health Professionals Follow-up Study.

Potential mediation effect of insulin resistance on the association between iron metabolism indicators and non-alcoholic fatty liver disease

Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population

Serum Fetuin-B is Positively Associated with Intrahepatic Triglyceride Content and Increases the Risk of Insulin Resistance in Obese Chinese Adults: A Cross-Sectional Study.

Obesity, insulin resistance and their interaction on liver enzymes